Higher levels of CRP in C3-AITL patients might be explained by the higher frequency of either IDH2 or multiple TET2 mutations, as Tet2 recruits Hdac2 and represses IL-6 transcription via histone deacetylation [51]. The gene discussed is HDAC2; the disease is angioimmunoblastic T-cell lymphoma.